Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.22.2
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Total revenues $ 29,819 $ 26,266 $ 46,554 $ 107,284
Costs and expenses:        
Cost of product sales 1,036 129 1,157 445
Research and development 14,767 16,807 30,241 33,633
Selling, general and administrative 26,981 22,378 54,382 44,499
Total costs and expenses 42,784 39,314 85,780 78,577
Income (loss) from operations (12,965) (13,048) (39,226) 28,707
Interest income 42 16 63 17
Interest expense (569) (1,759) (1,774) (2,244)
Income (loss) before income taxes (13,492) (14,791) (40,937) 26,480
Provision for (benefit from) income taxes 0 (970) 0 801
Net income (loss) $ (13,492) $ (13,821) $ (40,937) $ 25,679
Net income (loss) per share, basic and diluted        
Basic (in dollars per share) $ (0.08) $ (0.08) $ (0.24) $ 0.15
Diluted (in dollars per share) $ (0.08) $ (0.08) $ (0.24) $ 0.15
Weighted average shares used in computing net income (loss) per share, basic and diluted        
Basic (in shares) 172,147 170,192 171,961 169,997
Diluted (in shares) 172,147 170,192 171,961 175,912
Product sales, net        
Total revenues $ 18,550 $ 17,053 $ 34,747 $ 29,429
Revenues from collaborations        
Total revenues $ 11,269 3,713 $ 11,807 69,355
Government contract        
Total revenues   $ 5,500   $ 8,500